Literature DB >> 8714022

Novel approach to oxytocin induction-augmentation of labor. Application of oxytocin physiology during pregnancy.

M Y Dawood1.   

Abstract

New information and understanding about the physiology of oxytocin (OT) have provided the bases of novel and rational approaches to the induction and augmentation of labor with OT. Based on a half-life of 8-10 min and time to steady state of 20 min, the interval between intravenous OT dose increments during uterine stimulation should be 20-30 min. Feto-maternal blood plasma gradients of OT concentration in spontaneous labor at term indicate a feto-uterine flow of 2-4mU OT/min. Labor can be successfully induced in most women with such physiological doses (2-6 mU/min) of OT given intravenously. Direct and indirect evidence show that OT is released in pulses with the frequency and/or amplitude of the pulses increasing with or during spontaneous labor. Further OT interaction with its receptor renders it occupied and temporarily unavailable. We have therefore employed these observations to induce and augment labor with pulsatile intravenous administration of OT. In a prospective randomized study of 106 patients undergoing labor induction with pulsatile versus continuous administration of OT, the total dose, the average dose/min, and the peak or highest dose required/min were significantly reduced with pulsatile OT compared with continuous OT. These significant differences remained when controlled for parity, Bishop's score of cervical ripeness, and the number of days for induction. Similarly in a prospective randomized study on augmentation of labor by intravenous OT, we found the dose of OT for successful augmentation was significantly reduced with pulsatile OT compared with continuous OT. Thus, pulsatile OT not only is safe and requires less OT for uterine stimulation, but also constitutes a more physiological basis for uterine stimulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8714022

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.

Authors:  S R Hawtin; H C Howard; M Wheatley
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Evaluation of the oxytocin effect in a rat model with experimental periodontitis.

Authors:  Tuğçe Paksoy; Gülbahar Ustaoğlu; Ahmet Özer Şehirli; Revan Birke Koca Ünsal; Serkan Sayıner; Kaan Orhan; Nurdan Bülbül Aycı; Şule Çetinel; Umut Aksoy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-17       Impact factor: 3.195

Review 3.  Intravenous oxytocin alone for cervical ripening and induction of labour.

Authors:  Zarko Alfirevic; Anthony J Kelly; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

4.  The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.

Authors:  Nikolaos Vrachnis; Fotodotis M Malamas; Stavros Sifakis; Efthymios Deligeoroglou; Zoe Iliodromiti
Journal:  Int J Endocrinol       Date:  2011-12-06       Impact factor: 3.257

5.  Continued versus discontinued oxytocin after the active phase of labor: An updated systematic review and meta-analysis.

Authors:  Danni Jiang; Yang Yang; Xinxin Zhang; Xiaocui Nie
Journal:  PLoS One       Date:  2022-05-02       Impact factor: 3.752

Review 6.  Locally Applied Repositioned Hormones for Oral Bone and Periodontal Tissue Engineering: A Narrative Review.

Authors:  Gamal Abdel Nasser Atia; Hany K Shalaby; Mehrukh Zehravi; Mohamed Mohamady Ghobashy; Zubair Ahmad; Farhat S Khan; Abhijit Dey; Md Habibur Rahman; Sang Woo Joo; Hasi Rani Barai; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-07-21       Impact factor: 4.967

7.  Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells.

Authors:  Jason N A Pont; Craig A McArdle; Andrés López Bernal
Journal:  Mol Endocrinol       Date:  2012-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.